Annals of Vascular Surgery - Brief Reports and Innovations (Jun 2022)
The refractory effective of unfractionated heparin during an open aneurysm repair post-andexanet administration: A case report
Abstract
Andexanet alpha is a reversal agent for the direct factor Xa inhibitors including apixaban and rivaroxaban in situations of life-threatening or uncontrolled bleeding. The effect of andexanet alpha on other anticoagulants including unfractionated heparin is less well described but important to consider particularly in situations of emergency cardiac or vascular surgery cases. The current case report describes the complicated course of anticoagulation for a ruptured abdominal aortic aneurysm operation where andexanet administration resulted in thrombotic complications and need for alternative anticoagulant therapy.